Controlling Behcet's Uveitis Through Transfer of Ex-Vivo Expanded Regulatory T Cells
Brief description of study
The purpose of this study is to see whether we can massively expand autoantigen-specific Treg clones from patients with Behcet's Disease (BD), in particular in those with Behcet's Eye Disease (BED), in the following referred to as Behcet's Uveitis (BU), in order to set the stage for their subsequent testing in animal models, and, later, humans, as a potential immune-based therapeutic intervention.
Clinical Study Identifier: S14-00157
Principal Investigator:
Johannes Nowatzky.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
